Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03039725 · ClinicalTrials.gov registry record
Vaccination Compliance
A clinical trial of Vaccine Compliance, sponsored by Jaye Shyken, MD.
- Completed
- Registry status
- 99
- Enrollment target
- 1
- Study location
NCT03039725: Completed study of Vaccine Compliance, sponsored by Jaye Shyken, MD.
NCT03039725 is a study of Vaccine Compliance that has completed, run by Jaye Shyken, MD. The registered enrollment target is 99 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03039725, a study of Vaccine Compliance, has completed, sponsored by Jaye Shyken, MD.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
Retrospective study to assess a single Clinic on Immunization Practices (ACIP) recommendations for hepatitis A, hepatitis B, influenza, tetanus/diphtheria/pertussis, HPV and pneumococcal disease
Primary Outcome
Chart review
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
Missouri
- St. Mary's Health Center - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2017-08-28 |
What the finished NCT03039725 record still lists
NCT03039725 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 1 condition, with Vaccine Compliance appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT03039725 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03039725 about?
NCT03039725 is a clinical study titled "Vaccination Compliance". Retrospective study to assess a single Clinic on Immunization Practices (ACIP) recommendations for hepatitis A, hepatitis B, influenza, tetanus/diphtheria/pertussis, HPV and pneumococcal disease
What is the current status of trial NCT03039725?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2017-05-01. Estimated completion is 2017-08-28.
What conditions does trial NCT03039725 study?
This clinical trial studies the following conditions: Vaccine Compliance.
What interventions are being tested in trial NCT03039725?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT03039725?
This trial is sponsored by Jaye Shyken, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03039725 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI